Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research. Grossman I, Knappertz V, Laifenfeld D, Ross C, Zeskind B, Kolitz S, Ladkani D, Hayardeny L, Loupe P, Laufer R, et al. Prog Neurobiol. 2016 Mar 4. PMID: 26952809. Abstract CommentRecommendBookmarkWatch